NDC 0781-2329 – Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate

Dextroamphetamine Saccharate 1.25 mg/1; Amphetamine Aspartate Monohydrate 1.25 mg/1; Dextroamphetamine Sulfate 1.25 mg/1; Amphetamine Sulfate 1.25 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC0781-2329

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Generic name
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE
Labeler
Sandoz Inc
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
NDA AUTHORIZED GENERIC · NDA021303
Marketed since
April 2, 2009
Marketing end
February 28, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
0781-2329-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0781-2329-01)Apr 2, 2009

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products